Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cost-Effectiveness and Cost-Utility Analysis of Type-2 Diabetes Screening in Pharmacies in Iran Publisher



Amirsadri M1, 2 ; Torkpour E2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Health Management and Economics Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Research in Pharmaceutical Sciences Published:2023


Abstract

Background and purpose: Several studies have shown the effectiveness of screening programs in decreasing the costs and disutility of type-2 diabetes and related complications. As there is a growth in the incidence of type-2 diabetes amongst the Iranian population, the cost-effectiveness of performing type-2 diabetes screening tests in community pharmacies of Iran was evaluated in this study from the payer's perspective. The target population consisted of two hypothetical cohorts of 1000 people 40 years of age without a prior diagnosis of diabetes, for the intervention (screening test) and no-screening groups. Experimental approach: A Markov model was developed to evaluate the cost-effectiveness and cost-utility of a type-2 diabetes screening test in community pharmacies in Iran. A 30-year time horizon was considered in the model. Three screening programs with 5-year intervals were considered for the intervention group. The evaluated outcomes were quality-adjusted life-years (QALYs) for cost-utility-analysis and life-years-gained (LYG) for cost-effectiveness-analysis. To examine the robustness of the results, one-way and probabilistic-sensitivity analyses were applied to the model. Findings/Results: The screening test represented both more effects and higher costs. The incremental effects in the base-case scenario (no-discounting) were estimated to be 0.017 and 0.0004 (approximately 0) for QALYs and LYG, respectively. The incremental cost was estimated to be 2.87 USD/patient. The estimated incremental-cost-effectiveness ratio was 164.77 USD/QALY. Conclusion and implications: This study indicated that screening for type-2 diabetes in community pharmacies of Iran could be considered highly cost-effective, as it meets the WHO criteria of the annual GDP per capita ($2757 in 2020). © 2023 Wolters Kluwer Medknow Publications. All rights reserved.
Related Docs
View other Related Docs
1. The Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective Study, International Journal of Preventive Medicine (2016)
2. Cost-Effectiveness and Cost-Utility Analysis of Otc Use of Simvastatin 10 Mg for the Primary Prevention of Myocardial Infarction in Iranian Men, DARU, Journal of Pharmaceutical Sciences (2015)
3. Evaluating the Impact of a Clinical Breast Examination Screening Program Within the Irapen Project, Asian Pacific Journal of Cancer Prevention (2024)
4. Establishment of Health Clinics As Mass Screening and Referral Systems for Chronic Non-Communicable Diseases in Primary Health Care, International Journal of Preventive Medicine (2012)
5. Quality of Care for First-Degree Relatives of Type 2 Diabetes Patients Diagnosed With Diabetes at a Screening Program One Year After Diagnosis, Review of Diabetic Studies (2008)
6. Coronary Bypass Surgery Versus Percutaneous Coronary Intervention: Cost-Effectiveness in Iran: A Study in Patients With Multivessel Coronary Artery Disease, International Journal of Technology Assessment in Health Care (2014)
7. Assessment of Caring Status for Patients With Type 2 Diabetes in Under Control Health Centers of Jarghoyee Region in Isfahan, Iran, Journal of Isfahan Medical School (2017)
8. Model-Based Cost-Effectiveness Analysis of Atorvastatin Drugs for Prevention of Cardiovascular Diseases in Iran, International Journal of Preventive Medicine (2020)
Experts (# of related papers)
View all Related Experts
Mohammadreza Amirsadri (4)
Amir Hooshang Zargarzadeh (4)
Other Related Docs
9. A Survey on the Extent of Medication Storage and Wastage in Urban Iranian Households, Clinical Therapeutics (2005)
10. Cost-Effectiveness Analysis of the Introduction of Hpv Vaccination of 9-Year-Old-Girls in Iran, Value in Health Regional Issues (2018)
11. Variations in Diabetes Prevalence in Low-, Middle-, and High-Income Countries: Results From the Prospective Urban and Rural Epidemiological Study, Diabetes Care (2016)
12. The Effect of Home Care on Readmission and Mortality Rate in Patients With Diabetes Who Underwent General Surgeries, Journal of Education and Health Promotion (2021)
13. Women’S Willingness to Pay for Mammography Screening Under Two Medical Information Scenarios, European Journal of Cancer Care (2023)
14. Exploring the Barriers of Adherence to Dietary Recommendations Among Patients With Type 2 Diabetes: A Qualitative Study in Iran, Nursing Open (2020)
15. Cost-Effectiveness of Colorectal Cancer Screening Strategies: A Systematic Review, European Journal of Cancer Care (2022)
16. The Cost-Effectiveness and Cost-Utility Analysis of the Use of Enoxaparin Compared With Heparin for Venous Thromboembolism Prophylaxis in Medical Inpatients in Iran, DARU, Journal of Pharmaceutical Sciences (2019)
17. Descriptive Phenomenology Study of the Reasons for the Low Uptake of Free Health Service Package Among Type Ii Diabetic Patients, BMC Health Services Research (2022)
18. The Economic Cost of Cancer Treatment in Iran, Journal of Education and Health Promotion (2023)
19. Costs and Outcomes of Colorectal Cancer Screening Program in Isfahan, Iran, BMC Health Services Research (2023)
20. The Drug Prescription Patterns and Utilization After Family Physician Program Implementation in Rural Health Centers of Isfahan District, Iran, Journal of Isfahan Medical School (2014)
21. Impact of Pharmaceutical Care on Quality of Life in Patients With Type 2 Diabetes Mellitus, Journal of Research in Medical Sciences (2011)
22. Cost Evaluation of Chemotherapy and Epidemiology of Five Most Common Cancers in Isfahan Province in Iran, Tehran University Medical Journal (2020)
23. The Direct Medical Costs of Breast Cancer in Iran: Analyzing the Patient's Level Data From a Cancer Specific Hospital in Isfahan, International Journal of Preventive Medicine (2013)
24. Breast Cancer Screening and Early Detection Programs in Iran: A Health Policy Analysis and Recommendations, World Medical and Health Policy (2024)
25. Comparing the Quality of Life in Insulin Recipient and Refusal Patients With Type 2 Diabetes, Iranian Journal of Nursing and Midwifery Research (2016)
26. Quality of Life in People With Type 2 Diabetes Living in Rural and Remote Areas, Iran, International Journal of Diabetes in Developing Countries (2015)
27. Prevalence of Uncontrolled Diabetes and Its Predictors in Patients With Type 2 Diabetes Covered by Comprehensive Health Care Centers of Isfahan, Iranian Journal of Endocrinology and Metabolism (2022)
28. Cost-Effectiveness Analysis of Colorectal Cancer Screening Methods in Iran, Archives of Iranian Medicine (2011)
29. Predictors of Switching to Insulin From Non-Insulin Therapy in Patients With Type 2 Diabetes Mellitus, Diabetes Research and Clinical Practice (2011)
30. Community Pharmacists' Performance in Management of Cough, Diarrhea and Obesity Using Over-The-Counter Medications, Journal of Isfahan Medical School (2013)
31. Cost-Effectiveness of Hypertension Therapy Based on 2020 International Society of Hypertension Guidelines in Ethiopia From a Societal Perspective, PLoS ONE (2022)
32. The Pattern of Costs by the Health Insurance Organization for the People in Urban Areas With Population Under Twenty Thousands and Nomads in Isfahan Province, Iran, 2009-2013, Journal of Isfahan Medical School (2016)
33. Cost-Effectiveness Evaluation of Aspirin in Primary Prevention of Myocardial Infarction Amongst Males With Average Cardiovascular Risk in Iran, Research in Pharmaceutical Sciences (2017)
34. Results of the Program for Prevention and Control of Non-Communicable Diseases in Isfahan, Scientific Journal of Kurdistan University of Medical Sciences (2021)
35. Normative Data and Psychometric Properties of the Quality of Life Questionnaire for Patients With Diabetes Mellitus, Koomesh (2010)
36. Iran Quality of Care in Medicine Program (Iqcamp): Design and Outcomes, Archives of Iranian Medicine (2023)
37. Estimation and Prediction of Avoidable Health Care Costs of Cardiovascular Diseases and Type 2 Diabetes Through Adequate Dairy Food Consumption: A Systematic Review and Micro Simulation Modeling Study, Archives of Iranian Medicine (2018)
38. Survey of Patients’ Awareness of the Actual Cost of Visits in Relation to Their Individual Responsibility for Health, Journal of Public Health (Germany) (2025)
39. Prevalence, Incidence and Ecological Determinants of Diabetic Retinopathy in Iran: Systematic Review and Meta-Analysis, Journal of Ophthalmic and Vision Research (2019)
40. The Use and the Cost of Outpatient Diagnostic Procedures for Cardiovascular Diseases in Isfahan Province: A Utilization Study, Journal of Education and Health Promotion (2022)
41. Private and Social Time Preference for Health Outcomes: A General Population Survey in Iran, PLoS ONE (2019)
42. Metabolic Risk Factors Attributed Burden in Iran at National and Subnational Levels, 1990 to 2019, Frontiers in Public Health (2023)
43. The Assessment of Family Physicians' Performance in Screening of Hypertension and Diabetes Mellitus in Rural Areas of Isfahan County: A 5-Year Survey, Journal of Isfahan Medical School (2012)
44. Finnish Diabetes Risk Score to Predict Type 2 Diabetes in the Isfahan Diabetes Prevention Study, Diabetes Research and Clinical Practice (2013)
45. Availability and Affordability of Essential Medicines for Diabetes Across High-Income, Middle-Income, and Low-Income Countries: A Prospective Epidemiological Study, The Lancet Diabetes and Endocrinology (2018)
46. Evaluation of the Finnish Diabetes Risk Score (Findrisc) As a Screening Tool for the Metabolic Syndrome, The review of diabetic studies : RDS (2013)
47. Estimating Out-Of-Pocket Payments Among Iranian Women With Breast Cancer, International Journal of Cancer Management (2023)
48. Prescription and Nonprescription Drug Use in Isfahan, Iran: An Observational, Cross-Sectional Study, Current Therapeutic Research - Clinical and Experimental (2008)
49. A Scoping Review of Possible Solutions for Decreasing Socioeconomic Inequalities in Type 2 Diabetes Mellitus, International Journal of Preventive Medicine (2024)
50. Cost-Utility Analysis of Combination Medical Therapies in Chronic Coronary Syndrome: A Comparative Study Using Real-World and Patient-Level Data From Iran, BMJ Open (2025)